| Metric | Current Period | YoY (Prior-Year Q3) | YoY |
|---|---|---|---|
| Revenue | ¥53.0B | ¥52.5B | +1.0% |
| Operating Income | ¥2.6B | ¥3.1B | -17.5% |
| Ordinary Income | ¥3.3B | ¥4.0B | -17.9% |
| Net Income | ¥2.1B | ¥2.6B | -19.7% |
| ROE | 3.2% | 4.1% | - |
In 2026 Q3, Revenue was ¥53.0B (YoY +¥0.5B +1.0%), roughly flat; Operating Income was ¥2.6B (YoY -¥0.6B -17.5%), Ordinary Income ¥3.3B (YoY -¥0.7B -17.9%), and Net Income ¥2.1B (YoY -¥0.5B -19.7%), resulting in lower earnings. While Revenue remained firm, SG&A of ¥9.4B increased from the prior-year period, pushing the Operating Margin down to 4.9%. For the FY outlook, the company guides for Revenue of ¥70.7B (YoY +1.9%) and Operating Income of ¥4.0B (YoY +9.5%), expecting Operating Income growth in H2.
[Profitability] ROE 3.2% (down from the prior-year period), Operating Margin 4.9% (down -1.0pt from 5.9% in the prior-year period), Net Margin 4.0% (down -1.0pt from 5.0% in the prior-year period). The Gross Margin remained at 22.6%, but an increase in SG&A to 17.7% (from 16.1% in the prior-year period) compressed the Operating Margin. The effective tax rate was 35.7%, with a high tax burden weighing on Net Income. [Cash Quality] Cash and deposits ¥10.0B; cash coverage to short-term liabilities 0.97x, indicating limited near-term payment capacity. Interest coverage 10.9x, indicating sound debt service capacity. [Investment Efficiency] Total Asset Turnover 0.48x, ROIC 2.2%, reflecting low capital efficiency. Financial leverage 1.65x. [Financial Soundness] Equity Ratio 60.6% (down from 63.5% in the prior-year period), Current Ratio 71.0%, below 1.0x, flashing a liquidity warning; Short-term Debt Ratio 51.0%, elevated, requiring attention to refinancing risk. Interest-bearing debt ¥20.2B (short-term borrowings ¥10.3B, long-term borrowings ¥9.9B), Debt-to-Equity Ratio 0.30x. Working capital is -¥8.8B, indicating tight short-term funding.
Cash and deposits were ¥10.0B, almost flat, down -¥0.1B YoY. On working capital, accounts payable increased sharply by +¥2.8B (+42.7%) YoY, indicating a cash flow improvement effect via trade payables; however, with current liabilities at ¥30.5B versus current assets at ¥21.6B, working capital was -¥8.8B, constraining short-term payment capacity. In investing activities, investment securities increased by +¥0.8B (+25.7%) YoY, suggesting strategic investments or surplus cash management. In financing activities, long-term borrowings increased by +¥2.9B (+40.4%) YoY, securing long-term funding; interest expenses were ¥0.2B with an interest burden factor of 1.27x, implying interest costs are diluting EBIT to some extent. Short-term borrowings of ¥10.3B are covered by cash and deposits of ¥10.0B, a 0.97x coverage, indicating limited short-term repayment capacity; stable generation of Operating Cash Flow (OCF) is key to maintaining liquidity.
Against Ordinary Income of ¥3.3B, Operating Income was ¥2.6B, implying a net non-operating gain of approximately ¥0.7B. The breakdown comprises non-operating income of ¥0.9B (including dividend income of ¥0.1B) less non-operating expenses of ¥0.2B (interest expenses, etc.), with non-operating income accounting for 1.8% of Revenue. There is no disclosure of equity-method investment gains, and dividend income and miscellaneous income appear to be the main drivers. While detailed OCF data are not available, the substantial increase in accounts payable (+42.7%) suggests a payment deferral effect in working capital management, potentially supporting the cash underpinning of earnings to some extent. The tax burden factor is 0.64, and the effective tax rate is 35.7%, indicating a high tax burden; improving tax efficiency would enhance earnings quality. With an interest burden factor of 1.27x, interest costs in non-operating expenses are diluting profits, and the conversion rate from Operating Income to Ordinary Income is approximately 127%, indicating that non-operating factors are adding to earnings to some extent.
Liquidity Risk: With a Current Ratio of 71.0% below the 1.0x benchmark, working capital of -¥8.8B, and a Short-term Debt Ratio of 51.0% at a high level, short-term funding risks are materializing. Cash and deposits of ¥10.0B roughly match short-term borrowings of ¥10.3B, leaving limited short-term repayment capacity. Risk of Rising SG&A: SG&A increased from the prior-year period, with the SG&A ratio at 17.7% (16.1% in the prior-year period). SG&A growth outpaced Revenue growth of +1.0%, muting operating leverage and compressing margins. The breakdown of SG&A is unknown, and it is necessary to assess whether the increase is structural or one-off investment. Capital Efficiency Risk: ROIC 2.2% and ROE 3.2% are low, limiting the effectiveness of capital allocation. Total Asset Turnover at 0.48x is also low, and returns on invested capital may significantly trail industry levels.
[Industry Positioning] (Reference Information - In-house Research) Profitability: Operating Margin 4.9% (3.3pt below the industry median of 8.2%), Net Margin 4.0% (1.7pt below the industry median of 5.7%), ROE 3.2% (6.5pt below the industry median of 9.7%). The company’s Operating and Net Margins are below the industry median, placing its profitability in the lower tier within the industry. Soundness: Equity Ratio 60.6% (11.6pt above the industry median of 49.0%), indicating high financial soundness within the industry; however, the Current Ratio is 71.0% (far below the industry median of 206.0%), making short-term liquidity notably inferior within the industry. Net Debt/EBITDA is not computable, but against the industry median of -1.75x, the company’s interest-bearing debt of ¥20.2B versus cash of ¥10.0B yields positive Net Debt, indicating a relatively higher debt burden. Growth: Revenue growth rate +1.0% (8.5pt below the industry median of +9.5%), indicating low growth within the industry. Efficiency: ROA 1.9% (2.8pt below the industry median of 4.7%), placing asset efficiency at a low level within the industry. While the company secures financial stability with a high Equity Ratio, it trails the industry median across profitability, liquidity, growth, and capital efficiency, positioning it as strong on defense but weak on offense within the industry. Industry: Healthcare (N=44 companies), Comparison: 2025 Q3, Source: In-house aggregation
Top Priority: SG&A Management and Operating Efficiency Improvement: The SG&A ratio rose to 17.7%, up +1.6pt from 16.1% in the prior-year period, depressing the Operating Margin; therefore, analyzing the breakdown of SG&A and potential reductions is a key point for this earnings release. The FY outlook assumes improvement in Operating Income (Operating Margin 5.7%); attention focuses on whether SG&A control in H2 will be realized. Liquidity Management and Working Capital Efficiency: With a Current Ratio of 71.0% and working capital of -¥8.8B constraining short-term funding, the substantial increase in accounts payable (+42.7%) confirms a working capital adjustment effect. The evolution of the receivables–inventory–payables cycle and stable OCF generation will be key to maintaining liquidity. Assessing Room to Improve Capital Efficiency: With ROIC at 2.2% and ROE at 3.2%—well below the industry median ROE of 9.7%—the feasibility of measures to enhance returns on invested capital (improving asset turnover, improving margins, utilizing leverage) will be a criterion for medium- to long-term shareholder value creation.
This report is an automatically generated earnings analysis produced by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmark is reference information aggregated by our firm based on publicly available financial statements. Investment decisions are your own responsibility; consult a professional as needed before making any investment decisions.